Garlic: A Closer Look at its Benefits, Drawbacks, and Who Should Consume or Avoid It

Garlic: A Closer Look at its Benefits, Drawbacks, and Who Should Consume or Avoid It


Garlic or Allium sativum scientifically is one of the popular plants that is known by its taste in foods as well as being of medicinal important.

A Closer Look at Garlic Benefits, Drawbacks, and Who Should Consume or Avoid It
Garlic Benefits, Drawbacks, and Who Should Consume or Avoid It

Thus, this review states about its enormous benefits, for example being full of essential nutrients, antioxidants, which can improve heart health, have immune-boosting properties. Yet, the main drawback is digestive problems as well as the fact that that it may interfere with medications.

Benefits of Garlic

Disadvantages of Garlic

Containing most of the necessary nutrients like manganese, vitamin B6, vitamin C, selenium, and fibre.

Gastric conditions like flatulence, belching and heartburn as possible digestion concerns.

Powerful antioxidant properties

Can give off the body odor and bad breath (halitosis)

Helps to maintain heart health by reducing blood pressure and cholesterol levels.

Some individuals may experience skin irritation or allergic reactions.

Shows antibacterial and antiviral properties, helping to fight infections.

Interactions with certain medications, which will require more caution.

Anti-inflammatory action in turn may decrease the risk of chronic diseases

 

Strengthens immune function

 

Potential cancer-preventive properties

 


While garlic is beneficial for healthy individuals, it might be possibly dangerous for those with allergic qualities or for people with particular illnesses.

Who Should Eat Garlic

Who Should Avoid Garlic

Individuals in perfect health seeking to enhance total well–being

Individuals allergic to garlic

The ones with heart diseases or with high cholesterol

Those digestive irritants, e.g. acid reflux or IBS.

People with weakened immune systems

Those using medicines suspected to get along with garlic.

No comments